Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes.
作者信息
Xin Yiqiao, Davies Andrew, McCombie Louise, Briggs Andrew, Messow C-Martina, Grieve Eleanor, Leslie Wilma S, Taylor Roy, Lean Michael E J
机构信息
Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow G31 2ER, UK.
出版信息
Lancet Diabetes Endocrinol. 2019 Mar;7(3):169-172. doi: 10.1016/S2213-8587(18)30346-2. Epub 2018 Dec 20.
Abstract
摘要
相似文献
1
Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes.
Lancet Diabetes Endocrinol. 2019 Mar;7(3):169-172. doi: 10.1016/S2213-8587(18)30346-2. Epub 2018 Dec 20.
2
Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight-Plus weight management programme within a primary care randomized controlled trial.
Diabet Med. 2019 Aug;36(8):1003-1012. doi: 10.1111/dme.13981.
3
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme.
Diabetologia. 2020 Oct;63(10):2112-2122. doi: 10.1007/s00125-020-05224-2. Epub 2020 Aug 10.
4
The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial.
BMC Fam Pract. 2016 Feb 16;17:20. doi: 10.1186/s12875-016-0406-2.
5
Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes.
Diabetologia. 2025 May;68(5):969-980. doi: 10.1007/s00125-024-06355-6. Epub 2025 Jan 23.
6
Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction).
Health Technol Assess. 2017 Jan;21(4):1-62. doi: 10.3310/hta21040.
7
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
Lancet Diabetes Endocrinol. 2019 May;7(5):344-355. doi: 10.1016/S2213-8587(19)30068-3. Epub 2019 Mar 6.
8
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care--an international randomised controlled trial.
Int J Obes (Lond). 2013 Jun;37(6):828-34. doi: 10.1038/ijo.2012.139. Epub 2012 Aug 28.
9
The DiRECT principles: giving Type 2 diabetes remission programmes the best chance of success.
Diabet Med. 2019 Dec;36(12):1703-1704. doi: 10.1111/dme.14126. Epub 2019 Oct 11.
10
Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial.
Lancet. 2017 Jun 3;389(10085):2214-2225. doi: 10.1016/S0140-6736(17)30647-5. Epub 2017 May 3.
引用本文的文献
1
Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial.
Diabetes Obes Metab. 2025 Oct;27(10):5930-5937. doi: 10.1111/dom.16650. Epub 2025 Jul 24.
2
Normalisation and equity of referral to the NHS Low Calorie Diet programme pilot; a qualitative evaluation of the experiences of health care staff.
BMC Public Health. 2024 Jan 11;24(1):152. doi: 10.1186/s12889-023-17526-2.
3
Barriers to and enablers of postpartum health behaviours among women from diverse cultural backgrounds with prior gestational diabetes: A systematic review and qualitative synthesis applying the theoretical domains framework.
Diabet Med. 2022 Nov;39(11):e14945. doi: 10.1111/dme.14945. Epub 2022 Sep 8.
4
ENDOCRINOLOGY IN PREGNANCY: Targeting metabolic health promotion to optimise maternal and offspring health.
Eur J Endocrinol. 2022 Apr 29;186(6):R113-R126. doi: 10.1530/EJE-21-1046.
5
Identifying women with gestational diabetes based on maternal characteristics: an analysis of four Norwegian prospective studies.
BMC Pregnancy Childbirth. 2021 Sep 8;21(1):615. doi: 10.1186/s12884-021-04086-9.
6
Remission of Type 2 Diabetes with Very Low-Calorie Diets-A Narrative Review.
Nutrients. 2021 Jun 18;13(6):2086. doi: 10.3390/nu13062086.
7
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme.
Diabetologia. 2020 Oct;63(10):2112-2122. doi: 10.1007/s00125-020-05224-2. Epub 2020 Aug 10.
8
Obesity indicators that best predict type 2 diabetes in an Indian population: insights from the Kerala Diabetes Prevention Program.
J Nutr Sci. 2020 Apr 6;9:e15. doi: 10.1017/jns.2020.8. eCollection 2020.
9
Effectiveness of Lifestyle Intervention for Type 2 Diabetes in Primary Care: the REAL HEALTH-Diabetes Randomized Clinical Trial.
J Gen Intern Med. 2020 Sep;35(9):2637-2646. doi: 10.1007/s11606-019-05629-9. Epub 2020 Jan 21.
10
Advances in the clinical management of type 2 diabetes: a brief history of the past 15 years and challenges for the future.
BMC Med. 2019 Feb 26;17(1):46. doi: 10.1186/s12916-019-1281-1.
本文引用的文献
1
Economic Costs of Diabetes in the U.S. in 2017.
Diabetes Care. 2018 May;41(5):917-928. doi: 10.2337/dci18-0007. Epub 2018 Mar 22.
2
Association between type 2 diabetes mellitus and disability: What is the contribution of diabetes risk factors and diabetes complications?
J Diabetes. 2018 Sep;10(9):744-752. doi: 10.1111/1753-0407.12659. Epub 2018 Apr 6.
3
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1. Epub 2017 Dec 5.
4
Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort.
Diabetologia. 2018 Mar;61(3):589-598. doi: 10.1007/s00125-017-4503-0. Epub 2017 Nov 30.
5
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
Diabetes Res Clin Pract. 2017 Jun;128:40-50. doi: 10.1016/j.diabres.2017.03.024. Epub 2017 Mar 31.
6
Cost of intervention delivery in a lifestyle weight loss trial in type 2 diabetes: results from the Look AHEAD clinical trial.
Obes Sci Pract. 2017 Mar;3(1):15-24. doi: 10.1002/osp4.92. Epub 2017 Feb 24.
7
The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial.
BMC Fam Pract. 2016 Feb 16;17:20. doi: 10.1186/s12875-016-0406-2.
8
Excess Mortality among Persons with Type 2 Diabetes.
N Engl J Med. 2015 Oct 29;373(18):1720-32. doi: 10.1056/NEJMoa1504347.
9
Association of an intensive lifestyle intervention with remission of type 2 diabetes.
JAMA. 2012 Dec 19;308(23):2489-96. doi: 10.1001/jama.2012.67929.
10
Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
Diabet Med. 2012 Jul;29(7):855-62. doi: 10.1111/j.1464-5491.2012.03698.x.
Zotero 插件